Results 11 to 20 of about 326,437 (300)

Antimicrobial, antibiofilm and antioxidant activities of Citrullus colocynthis fruit extracts [PDF]

open access: yesInternational Journal of Minor Fruits, Medicinal and Aromatic Plants, 2023
According to its beneficial characteristics, the desert medicinal plant Citrullus colocynthis L. is commonly used in traditional medicine. The objective of this study is to investigate the antioxidant, anti-hemolysis, antimicrobial, and antibiofilm ...
Mohammed Terki
doaj   +1 more source

Antifungal Drugs [PDF]

open access: yesQJM: An International Journal of Medicine, 1995
Introduction Fungi have been recognized as pathogens for many years. However, the incidence of fungal infections in the pediatric population has increased substantially due to the increased use of broad-spectrum antibiotics, immunosuppressive agents, hyperalimentation products, and central venous catheters in addition to the acquired ...
J T, Cross, S L, Hickerson, T, Yamauchi
openaire   +4 more sources

Antifungal Pipeline [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
In many ways, fungal diseases are forgotten or neglected. Given the significantly lower frequency compared to similar bacterial etiologies across the spectrum of infectious syndromes, it makes sense that anti-bacterial agents have seen the bulk of development in recent decades.
Todd Patrick McCarty   +2 more
openaire   +3 more sources

In vitro activities of Traganum nudatum and Mentha pulegium extracts combined with amphotericin B against Candida albicans in production of hydrolytic enzymes [PDF]

open access: yesCurrent Medical Mycology, 2020
Background and Purpose: Candida albicans is an important microorganism in the normal flora of a healthy subject; however, it has an expedient pathogenic character that induces hydrolytic virulence.
Ikram Tefiani   +2 more
doaj   +1 more source

Antifungal Peptides [PDF]

open access: yesJournal of Fungi, 2021
Fungal infections represent an increasing public health crisis [...]
openaire   +3 more sources

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]

open access: yes, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar   +20 more
core   +5 more sources

New Approaches for Cryptococcosis Treatment

open access: yesMicroorganisms, 2020
Cryptococcosis is an important opportunistic infection and a leading cause of meningitis in patients with HIV infection. The antifungal pharmacological treatment is limited to amphotericin B, fluconazole and 5- flucytosine.
Cristina de Castro Spadari   +3 more
doaj   +1 more source

Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis

open access: yesFrontiers in Microbiology, 2020
Topical drug administration is frequently used for the treatment of vaginal candidiasis; however, most formulations using this route do not provide prolonged drug release.
Fernanda Walt Mendes da Silva de Bastiani   +5 more
doaj   +1 more source

Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B

open access: yesMarine Drugs, 2019
The mangrove ecosystem is a rich resource for the discovery of actinomycetes with potential applications in pharmaceutical science. Besides the genus Streptomyces, Micromonospora is also a source of new bioactive agents.
Rui-Jun Wang   +8 more
doaj   +1 more source

Exploring hidden dimensions of soil fungal biodiversity: A simple technique to detect soil fungi resistant to antifungal compounds [PDF]

open access: yes, 2010
Soils are known to be ultimate and complex reservoirs of microbial diversity. The complex dimensions of bacterial and fungal diversity in tropical soils and microbial community dynamics are underexplored.
Sonashia Velho-Pereira   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy